MicroRNA Market to Grow with a CAGR of 12.20% through 2029
Rising prevalence of chronic diseases is expected to drive the Global MicroRNA Market growth in the forecast period.
According
to TechSci Research report, “MicroRNA Market - Global Industry Size, Share,
Trends, Competition, Opportunity and Forecast, 2019-2029F”. Global MicroRNA Market was valued at USD 1548.20 million
in 2023 and is anticipated to witness an impressive growth in the forecast
period with a CAGR of 12.20% through 2029. Collaborations and partnerships among leading companies play a pivotal role in bolstering their market position through the amalgamation of diverse expertise. The uptick in investment within the life sciences sector is a driving force behind the surge in demand for microRNA research, diagnostics, and therapeutics. Increased funding empowers researchers to delve deeper into the roles and functionalities of microRNAs, leading to the discovery of novel microRNAs, their involvement in various biological processes, and their potential as diagnostic and therapeutic targets. Investment in life sciences often catalyzes the development of state-of-the-art technologies and tools tailored for microRNA research. High-throughput sequencing, alongside advanced gene editing techniques such as CRISPR-Cas9, and innovative bioinformatics solutions, equip researchers with the capabilities to study microRNAs more comprehensively. Moreover, increased funding facilitates the identification of microRNAs as valuable biomarkers across a spectrum of diseases, spanning from cancer and neurodegenerative disorders to cardiovascular diseases and infectious diseases. This, in turn, fuels the development of microRNA-based diagnostic assays.
The influx of funding also fuels exploration into microRNAs as potential therapeutic targets in drug development endeavors. Life science companies and biotech firms channel investments into the research and development of microRNA-based therapeutics for various diseases. Such investments often pave the way for enhanced data sharing and collaboration among research institutions and life science companies. Collaborative research initiatives amplify the understanding of microRNA functions and applications, driving innovation and progress in the field.
MicroRNAs (miRNAs), small RNA molecules involved in gene regulation, are garnering attention in allergy research due to their potential as biomarkers and therapeutic targets. Bio-Techne Corporation's recent expansion of its RNAscope in situ hybridization portfolio, with the introduction of the RNAscope Plus smRNA-RNA detection assay, underscores the growing interest in miRNA detection technologies. This assay enables simultaneous fluorescent detection of a small regulatory RNA and three target RNAs or RNA biomarkers in tissue sections, offering single-cell and subcellular precision. Designed for scalability, it caters to large-scale studies and is compatible with the Leica Bond Rx platform and manual operation. Oligonucleotide therapies, including antisense oligonucleotides (ASOs) and RNA interference (RNAi), are emerging as a unique category of gene therapies with potential for targeted and durable effects. These therapies manipulate gene expression to treat inherited or acquired diseases that were previously challenging to manage.
Also, commercializing miRNA-based products poses significant challenges. Regulatory hurdles, such as obtaining approvals from agencies like the U.S. Food and Drug Administration (FDA), can be time-consuming and costly. Intellectual property (IP) issues, including patent disputes and licensing agreements, add further complexity, requiring negotiation with multiple stakeholders. Moreover, rigorous clinical validation is essential to demonstrate the safety, efficacy, and clinical utility of miRNA-based diagnostics and therapeutics, necessitating substantial investments in research and clinical studies. Generating robust data is crucial for successful market entry.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global MicroRNA Market”
Global MicroRNA Market is segmented based on Products
& Service, Application, End User, and by region.
Based
on the Application, Cancer stands as a prominent sector within the Global MicroRNA Market, primarily attributed to its robust demand for early detection, prognosis, and personalized treatment approaches. MicroRNAs play pivotal roles in the intricate landscape of cancer development and progression, serving not only as diagnostic biomarkers but also as therapeutic targets of immense significance. The market's traction in cancer research and development is further fueled by substantial efforts dedicated to pinpointing cancer-specific miRNA signatures. These signatures hold the promise of providing invaluable insights into the early detection and precise characterization of various cancer types. Consequently, there is a burgeoning demand for miRNA-based diagnostics and therapeutics tailored to meet the evolving needs of cancer management. The momentum in this segment is sustained by a continuous stream of clinical trials and collaborative endeavors between pharmaceutical entities and esteemed research institutions. These collaborations foster an environment conducive to innovation, where novel miRNA-based solutions are rigorously evaluated and refined. Such concerted efforts not only drive market growth but also pave the way for groundbreaking advancements in cancer diagnostics and treatment modalities.
Some of the major companies
operating in the Global MicroRNA
Market include:
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Horizon Discovery Ltd.
- Synlogic Inc.
- QIAGEN NV
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString Technologies, Inc.
Download Free Sample Report
Customers can also request
for 10% free customization on this report
“Certain areas, particularly in North
America, are projected to exert significant demand for MicroRNA. The growth in
the competitive landscape and the presence of well-established companies in the
market, committed to enhance the overall wellbeing of people each year, are
expected to contribute to a remarkable growth of the Global MicroRNA Market in
the forecast period," said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based Global management consulting firm.
"MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Instruments, Consumables, Services ), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), By End-User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other end-users) Region and Competition, 2019-2029F", has evaluated the future growth
potential of Global MicroRNA Market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide innovative market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in Global
MicroRNA Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com